3-methyl-1,3-thiazolidine-4-carboxylic acid hydrochloride, 1g

CIS-3-FLUORO-4-METHYLPIPERIDIN-4-OL, 95.0%, 100mg

3-chloro-N-(2-chloro-4,6-dimethylphenyl)propanamide, 95.0%, 1g

Magnesium Hydroxide, min. 95%, Ph.Eur., USP, granulated, 500 g, plastic packaging.

Diethyl Oxalacetate Sodium Salt>95.0%(T)500g

(3-Bromobutyl)benzene, 95+%, 250mg

2-Chloro-5-propylpyrimidine, 97.0%, 10g

Propynol ethoxylate, min. 98%, for synthesis, 500 ml, glass packaging

5-ETHYNYL-2-METHYLPYRIMIDINE, 95%, 5g

(Pyridin-2-ylmethylene)bis(4,1-phenylene) diacetate, 95.0%, 5g

2-((4-(2-Aminoethoxy)phenyl)amino)-6-(2,6-dichlorophenyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 99+%, 100mg

3-(4-Fluoro-phenyl)-1H-indole, 97.0%, 500mg

(R)-2-((tert-butoxycarbonyl)amino)-2-(naphthalen-2-yl)acetic acid, 95%, 1g